Status:
COMPLETED
Significance of the High-risk Hpv Viral Load
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
HPV Infections
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the significance of an elevated high-risk HPV (HR-HPV) viral load.
Detailed Description
We will particularly evaluate if the HR-HPV viral load: * Is correlated to the transcription of the genes of the oncoproteins E6 and E7 * Is predictive of the integration of the virus in infected cel...
Eligibility Criteria
Inclusion
- The women consulting for the therapeutic care (by hysterectomy or conization) of a LIEHG or a cervical cancer (carcinoma epidermoid or adenocarcinoma) confirmed by the anatomopathologique analysis of a preoperative cervical biopsy.
- The women having a normal cervix consulting for the surgical care by hysterectomy of a good-hearted pathology of the womb. The normality of the cervix will be confirmed by the anatomopathologique analysis of the detail of hysterectomy
- The patients participating in this study will have to be of more than 18 years old. All the subjects will be profitable of a regime of Social Security.
Exclusion
- The patients having a LIEBG
- The patients incapable to receive the information enlightened on the progress and the objectives of the study
- The patients not having signed enlightened assent
Key Trial Info
Start Date :
June 16 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2023
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT00682812
Start Date
June 16 2008
End Date
May 23 2023
Last Update
May 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Nord, service de gynécologie-obstétrique
Marseille, France, 13015